Reaction
Insulin-Requiring Type 2 Diabetes Mellitus reporting signals
As of the last recalculation, Insulin-Requiring Type 2 Diabetes Mellitus appears in 308 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is ZIPRASIDONE MESYLATE (PRR 79.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ziprasidone Mesylate | 16 | 79.9 | 80.0 |
| Olanzapine Pamoate | 41 | 77.9 | 78.0 |
| Ziprasidone | 16 | 64.7 | 64.8 |
| Sitagliptin And Metformin Hydrochloride | 19 | 63.4 | 63.4 |
| Lithium Carbonate | 14 | 58.3 | 58.4 |
| Sitagliptin | 47 | 51.8 | 51.9 |
| Exenatide | 19 | 25.9 | 25.9 |